SLC12A3 and diabetic kidney disease: The NCC is glycosylated at two sites (N404 and N424) located in the long extracellular loop and it is the site of action of the diuretic thiazide that is frequently administered to patients with T2DM suffering from diabetic nephropathy (see Fig. 1).